Pain Management of ACL Reconstruction
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Dec 1, 2017
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Specific Aim #1: To determine if there is a difference in opioid pain medication use following anterior cruciate ligament (ACL) reconstruction between an oral pain regimen versus adductor canal block.
Specific Aim #2: To determine if there is a difference in knee recovery and function post-operatively following ACL reconstruction between an oral pain regimen versus adductor canal block.
Specific Aim #3: To determine if cost-effectiveness or patient flow logistics of ACL reconstruction are affected by whether has patient has adductor canal block versus receiving oral pain medication regime...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 18 and 45 years old.
- • Clinical and/or advanced imaging confirmation of ACL tear of which reconstructive surgery is recommended and accepted.
- Exclusion Criteria:
- • No prior surgery of the affected and contralateral knee
- • Adults unable to consent
- • Children (age \< 18 years old)
- • Prisoners
- • Pregnant women
- • Inflammatory arthritis
- • Non-English-speaking patients
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Sacramento, California, United States
Patients applied
Trial Officials
Cassandra Lee, MD
Principal Investigator
UC-Davis Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials